Cargando…
Risk of Treatment Failure and Death after Ablation in Hepatocellular Carcinoma Patients—A Multiparametric Prediction
SIMPLE SUMMARY: Patients with early-stage BCLC 0/A hepatocellular carcinoma (HCC) who are not candidates for liver transplantation or resection are treated with percutaneous ablation according to guidelines. Nevertheless, these patients are at high risk of HCC recurrence and physicians must apply di...
Autores principales: | Muñoz-Martínez, Sergio, Sapena, Victor, García-Criado, Ángeles, Darnell, Anna, Forner, Alejandro, Belmonte, Ernest, Sanduzzi-Zamparelli, Marco, Rimola, Jordi, Soler, Alexandre, Llarch, Neus, Iserte, Gemma, Mauro, Ezequiel, Ayuso, Carmen, Rios, Jose, Bruix, Jordi, Vilana, Ramon, Reig, María |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10339895/ https://www.ncbi.nlm.nih.gov/pubmed/37444380 http://dx.doi.org/10.3390/cancers15133269 |
Ejemplares similares
-
Early diarrhoea under sorafenib as a marker to consider the early migration to second‐line drugs
por: Díaz‐González, Álvaro, et al.
Publicado: (2021) -
Activated Lymphocytes and Increased Risk of Dermatologic Adverse Events during Sorafenib Therapy for Hepatocellular Carcinoma
por: Corominas, Josep, et al.
Publicado: (2021) -
Portal Hypertension may Influence the Registration of Hypointensity of Small Hepatocellular Carcinoma in the Hepatobiliary Phase in Gadoxetic Acid MR
por: Caparroz, Carla, et al.
Publicado: (2022) -
Controversies in the management of hepatocellular carcinoma
por: Forner, Alejandro, et al.
Publicado: (2019) -
Mutational profile of skin lesions in hepatocellular carcinoma patients under tyrosine kinase inhibition: a repercussion of a wide-spectrum activity
por: da Fonseca, Leonardo G., et al.
Publicado: (2021)